{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T17:46:36Z","timestamp":1769276796013,"version":"3.49.0"},"reference-count":9,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1001\/jamaophthalmol.2018.1534","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T16:30:56Z","timestamp":1525969856000},"page":"820","source":"Crossref","is-referenced-by-count":10,"title":["Outcomes of Anti\u2013Vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization in Fellow Eyes of Previously Treated Patients With Neovascular Age-Related Macular Degeneration"],"prefix":"10.1001","volume":"136","author":[{"given":"Maxwell S.","family":"Stem","sequence":"first","affiliation":[{"name":"Associated Retinal Consultants, William Beaumont Hospital, Royal Oak, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Moinuddin","sequence":"additional","affiliation":[{"name":"Oakland University William Beaumont School of Medicine, Rochester, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah","family":"Kline","sequence":"additional","affiliation":[{"name":"Oakland University William Beaumont School of Medicine, Rochester, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristomenis","family":"Thanos","sequence":"additional","affiliation":[{"name":"Associated Retinal Consultants, William Beaumont Hospital, Royal Oak, Michigan"},{"name":"Devers Eye Institute, Legacy Health, Portland, Oregon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prethy","family":"Rao","sequence":"additional","affiliation":[{"name":"Associated Retinal Consultants, William Beaumont Hospital, Royal Oak, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Williams","sequence":"additional","affiliation":[{"name":"Associated Retinal Consultants, William Beaumont Hospital, Royal Oak, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek S.","family":"Hassan","sequence":"additional","affiliation":[{"name":"Associated Retinal Consultants, William Beaumont Hospital, Royal Oak, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"6","key":"ebr180011r1","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.ophtha.2012.11.041","article-title":"Incidence of visual impairment over a 20-year period: the Beaver Dam Eye Study.","volume":"120","author":"Klein","year":"2013","journal-title":"Ophthalmology"},{"issue":"8","key":"ebr180011r2","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","article-title":"Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the Comparison of Age-Related Macular Degeneration Treatments Trials.","volume":"123","author":"Maguire","year":"2016","journal-title":"Ophthalmology"},{"issue":"12","key":"ebr180011r3","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"issue":"2","key":"ebr180011r4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ophtha.2013.10.027","article-title":"Randomized trial of a home monitoring system for early detection of choroidal neovascularization: Home Monitoring of the Eye (HOME) Study.","volume":"121","author":"Chew","year":"2014","journal-title":"Ophthalmology"},{"issue":"10","key":"ebr180011r5","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1001\/archopht.125.10.1323","article-title":"Incident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration: SST report No. 20 from the Submacular Surgery Trials Research Group.","volume":"125","author":"Solomon","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"ebr180011r6","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ophtha.2006.10.045","article-title":"Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration.","volume":"114","author":"Boyer","year":"2007","journal-title":"Ophthalmology"},{"issue":"7","key":"ebr180011r7","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1097\/IAE.0b013e3182018df6","article-title":"Time to first treatment: the significance of early treatment of exudative age-related macular degeneration.","volume":"32","author":"Rauch","year":"2012","journal-title":"Retina"},{"issue":"3","key":"ebr180011r8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1001\/jamaophthalmol.2016.5314","article-title":"The potential importance of detection of neovascular age-related macular degeneration when visual acuity is relatively good.","volume":"135","author":"Ho","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"ebr180011r9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/bjophthalmol-2014-306229","article-title":"UK AMD EMR Users Group Report V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6\/12.","volume":"99","author":"Lee","year":"2015","journal-title":"Br J Ophthalmol"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2680109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T23:11:28Z","timestamp":1531437088000},"score":1,"resource":{"primary":{"URL":"http:\/\/archopht.jamanetwork.com\/article.aspx?doi=10.1001\/jamaophthalmol.2018.1534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.1534","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,1]]}}}